IVX 0.00% 0.4¢ invion limited

Ann: Investor Newsletter Q1 2014 , page-2

  1. 406 Posts.
    lightbulb Created with Sketch. 18
    So this newsletter says :

    "....Invion is remains heavily focussed on
    securing a partner for the INV103 (ala-Cpn10)"

    There are obviously clinical results available if they are having these types of dicussions. Will they release the outcomes...or is it better not to if the results are bad ? Good clinical results are generally released to the market !

 
watchlist Created with Sketch. Add IVX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.